< Back to all Breaking News
BTHE
9/24/2018 11:09am
Boston Therapeutics starts study of BTI320 on type 2 diabetics on metformin 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
